| 摘要 |
The invention refers to a human antibody, or its functional fragments, directed against the HCV E2 glycoprotein, able to have a neutralizing activity in vivo; a composition for anti-HCV therapy comprising in a therapeutically effective amount the antibody; a composition for topical use in gel, cream, ointment and ovule formulations; the use of the antibody for validating anti-HCV vaccines. |
